nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorescein—ABCB11—Dexamethasone—psoriatic arthritis	0.357	0.431	CbGbCtD
Fluorescein—ABCC1—Methotrexate—psoriatic arthritis	0.204	0.246	CbGbCtD
Fluorescein—CYP1A1—Dexamethasone—psoriatic arthritis	0.156	0.189	CbGbCtD
Fluorescein—SLC22A6—Methotrexate—psoriatic arthritis	0.11	0.133	CbGbCtD
Fluorescein—Dermatitis—Auranofin—psoriatic arthritis	0.00127	0.00732	CcSEcCtD
Fluorescein—Thrombophlebitis—Betamethasone—psoriatic arthritis	0.00126	0.00727	CcSEcCtD
Fluorescein—Thrombophlebitis—Dexamethasone—psoriatic arthritis	0.00126	0.00727	CcSEcCtD
Fluorescein—Extravasation—Methotrexate—psoriatic arthritis	0.00125	0.00723	CcSEcCtD
Fluorescein—Cardiac arrest—Prednisolone—psoriatic arthritis	0.00124	0.00717	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Triamcinolone—psoriatic arthritis	0.00124	0.00717	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Methylprednisolone—psoriatic arthritis	0.00124	0.00715	CcSEcCtD
Fluorescein—Skin discolouration—Methotrexate—psoriatic arthritis	0.00121	0.00699	CcSEcCtD
Fluorescein—Nausea—Auranofin—psoriatic arthritis	0.0012	0.00691	CcSEcCtD
Fluorescein—Pulmonary oedema—Prednisone—psoriatic arthritis	0.00116	0.00672	CcSEcCtD
Fluorescein—Cardiac arrest—Triamcinolone—psoriatic arthritis	0.00114	0.0066	CcSEcCtD
Fluorescein—Cardiac arrest—Methylprednisolone—psoriatic arthritis	0.00114	0.00658	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Dexamethasone—psoriatic arthritis	0.00113	0.0065	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Betamethasone—psoriatic arthritis	0.00113	0.0065	CcSEcCtD
Fluorescein—Respiratory failure—Methotrexate—psoriatic arthritis	0.00111	0.00643	CcSEcCtD
Fluorescein—Thrombophlebitis—Prednisone—psoriatic arthritis	0.0011	0.00633	CcSEcCtD
Fluorescein—Asthma—Triamcinolone—psoriatic arthritis	0.00104	0.006	CcSEcCtD
Fluorescein—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.00104	0.00598	CcSEcCtD
Fluorescein—Cardiac arrest—Betamethasone—psoriatic arthritis	0.00104	0.00598	CcSEcCtD
Fluorescein—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.00102	0.00588	CcSEcCtD
Fluorescein—Neoplasm—Methotrexate—psoriatic arthritis	0.000987	0.00571	CcSEcCtD
Fluorescein—Pulmonary oedema—Methotrexate—psoriatic arthritis	0.000972	0.00562	CcSEcCtD
Fluorescein—Bradycardia—Prednisolone—psoriatic arthritis	0.000919	0.00531	CcSEcCtD
Fluorescein—Thrombophlebitis—Methotrexate—psoriatic arthritis	0.000916	0.00529	CcSEcCtD
Fluorescein—Cardiac arrest—Prednisone—psoriatic arthritis	0.000902	0.00521	CcSEcCtD
Fluorescein—Bradycardia—Triamcinolone—psoriatic arthritis	0.000845	0.00489	CcSEcCtD
Fluorescein—Bradycardia—Methylprednisolone—psoriatic arthritis	0.000843	0.00487	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Methotrexate—psoriatic arthritis	0.000819	0.00473	CcSEcCtD
Fluorescein—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.000809	0.00467	CcSEcCtD
Fluorescein—Erythema—Prednisolone—psoriatic arthritis	0.000786	0.00454	CcSEcCtD
Fluorescein—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000769	0.00444	CcSEcCtD
Fluorescein—Bradycardia—Dexamethasone—psoriatic arthritis	0.000767	0.00443	CcSEcCtD
Fluorescein—Bradycardia—Betamethasone—psoriatic arthritis	0.000767	0.00443	CcSEcCtD
Fluorescein—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000752	0.00434	CcSEcCtD
Fluorescein—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000748	0.00432	CcSEcCtD
Fluorescein—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000747	0.00432	CcSEcCtD
Fluorescein—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000729	0.00421	CcSEcCtD
Fluorescein—Erythema—Triamcinolone—psoriatic arthritis	0.000723	0.00418	CcSEcCtD
Fluorescein—Erythema—Methylprednisolone—psoriatic arthritis	0.000721	0.00417	CcSEcCtD
Fluorescein—Malaise—Prednisolone—psoriatic arthritis	0.000709	0.0041	CcSEcCtD
Fluorescein—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000708	0.00409	CcSEcCtD
Fluorescein—Syncope—Prednisolone—psoriatic arthritis	0.000705	0.00407	CcSEcCtD
Fluorescein—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000691	0.00399	CcSEcCtD
Fluorescein—Asthma—Methotrexate—psoriatic arthritis	0.000685	0.00396	CcSEcCtD
Fluorescein—Angiopathy—Betamethasone—psoriatic arthritis	0.000684	0.00395	CcSEcCtD
Fluorescein—Angiopathy—Dexamethasone—psoriatic arthritis	0.000684	0.00395	CcSEcCtD
Fluorescein—Convulsion—Prednisolone—psoriatic arthritis	0.000681	0.00394	CcSEcCtD
Fluorescein—Hypertension—Prednisolone—psoriatic arthritis	0.000679	0.00392	CcSEcCtD
Fluorescein—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000671	0.00388	CcSEcCtD
Fluorescein—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000669	0.00387	CcSEcCtD
Fluorescein—Bradycardia—Prednisone—psoriatic arthritis	0.000668	0.00386	CcSEcCtD
Fluorescein—Discomfort—Prednisolone—psoriatic arthritis	0.000661	0.00382	CcSEcCtD
Fluorescein—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000657	0.0038	CcSEcCtD
Fluorescein—Erythema—Dexamethasone—psoriatic arthritis	0.000656	0.00379	CcSEcCtD
Fluorescein—Erythema—Betamethasone—psoriatic arthritis	0.000656	0.00379	CcSEcCtD
Fluorescein—Malaise—Triamcinolone—psoriatic arthritis	0.000652	0.00377	CcSEcCtD
Fluorescein—Malaise—Methylprednisolone—psoriatic arthritis	0.00065	0.00376	CcSEcCtD
Fluorescein—Syncope—Triamcinolone—psoriatic arthritis	0.000648	0.00375	CcSEcCtD
Fluorescein—Syncope—Methylprednisolone—psoriatic arthritis	0.000647	0.00374	CcSEcCtD
Fluorescein—Oedema—Prednisolone—psoriatic arthritis	0.000642	0.00371	CcSEcCtD
Fluorescein—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000642	0.00371	CcSEcCtD
Fluorescein—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000635	0.00367	CcSEcCtD
Fluorescein—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000634	0.00366	CcSEcCtD
Fluorescein—Shock—Prednisolone—psoriatic arthritis	0.000631	0.00365	CcSEcCtD
Fluorescein—Cough—Triamcinolone—psoriatic arthritis	0.000631	0.00365	CcSEcCtD
Fluorescein—Convulsion—Triamcinolone—psoriatic arthritis	0.000626	0.00362	CcSEcCtD
Fluorescein—Tachycardia—Prednisolone—psoriatic arthritis	0.000626	0.00362	CcSEcCtD
Fluorescein—Convulsion—Methylprednisolone—psoriatic arthritis	0.000625	0.00361	CcSEcCtD
Fluorescein—Hypertension—Triamcinolone—psoriatic arthritis	0.000624	0.00361	CcSEcCtD
Fluorescein—Hypertension—Methylprednisolone—psoriatic arthritis	0.000623	0.0036	CcSEcCtD
Fluorescein—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00062	0.00358	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00061	0.00352	CcSEcCtD
Fluorescein—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000609	0.00352	CcSEcCtD
Fluorescein—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000609	0.00352	CcSEcCtD
Fluorescein—Discomfort—Triamcinolone—psoriatic arthritis	0.000608	0.00351	CcSEcCtD
Fluorescein—Discomfort—Methylprednisolone—psoriatic arthritis	0.000607	0.00351	CcSEcCtD
Fluorescein—Angiopathy—Prednisone—psoriatic arthritis	0.000595	0.00344	CcSEcCtD
Fluorescein—Immune system disorder—Prednisone—psoriatic arthritis	0.000593	0.00343	CcSEcCtD
Fluorescein—Malaise—Betamethasone—psoriatic arthritis	0.000591	0.00342	CcSEcCtD
Fluorescein—Malaise—Dexamethasone—psoriatic arthritis	0.000591	0.00342	CcSEcCtD
Fluorescein—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00059	0.00341	CcSEcCtD
Fluorescein—Oedema—Triamcinolone—psoriatic arthritis	0.00059	0.00341	CcSEcCtD
Fluorescein—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000589	0.0034	CcSEcCtD
Fluorescein—Syncope—Dexamethasone—psoriatic arthritis	0.000588	0.0034	CcSEcCtD
Fluorescein—Syncope—Betamethasone—psoriatic arthritis	0.000588	0.0034	CcSEcCtD
Fluorescein—Shock—Triamcinolone—psoriatic arthritis	0.00058	0.00335	CcSEcCtD
Fluorescein—Shock—Methylprednisolone—psoriatic arthritis	0.000579	0.00335	CcSEcCtD
Fluorescein—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000577	0.00334	CcSEcCtD
Fluorescein—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000576	0.00333	CcSEcCtD
Fluorescein—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000576	0.00333	CcSEcCtD
Fluorescein—Paraesthesia—Prednisolone—psoriatic arthritis	0.000576	0.00333	CcSEcCtD
Fluorescein—Tachycardia—Triamcinolone—psoriatic arthritis	0.000576	0.00333	CcSEcCtD
Fluorescein—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000574	0.00332	CcSEcCtD
Fluorescein—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000572	0.0033	CcSEcCtD
Fluorescein—Erythema—Prednisone—psoriatic arthritis	0.000571	0.0033	CcSEcCtD
Fluorescein—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00057	0.0033	CcSEcCtD
Fluorescein—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000569	0.00329	CcSEcCtD
Fluorescein—Convulsion—Dexamethasone—psoriatic arthritis	0.000568	0.00328	CcSEcCtD
Fluorescein—Convulsion—Betamethasone—psoriatic arthritis	0.000568	0.00328	CcSEcCtD
Fluorescein—Hypertension—Betamethasone—psoriatic arthritis	0.000566	0.00327	CcSEcCtD
Fluorescein—Hypertension—Dexamethasone—psoriatic arthritis	0.000566	0.00327	CcSEcCtD
Fluorescein—Discomfort—Betamethasone—psoriatic arthritis	0.000552	0.00319	CcSEcCtD
Fluorescein—Discomfort—Dexamethasone—psoriatic arthritis	0.000552	0.00319	CcSEcCtD
Fluorescein—Hypotension—Methylprednisolone—psoriatic arthritis	0.00055	0.00318	CcSEcCtD
Fluorescein—Pain—Prednisolone—psoriatic arthritis	0.000549	0.00317	CcSEcCtD
Fluorescein—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000535	0.00309	CcSEcCtD
Fluorescein—Oedema—Dexamethasone—psoriatic arthritis	0.000535	0.00309	CcSEcCtD
Fluorescein—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000535	0.00309	CcSEcCtD
Fluorescein—Oedema—Betamethasone—psoriatic arthritis	0.000535	0.00309	CcSEcCtD
Fluorescein—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00053	0.00306	CcSEcCtD
Fluorescein—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00053	0.00306	CcSEcCtD
Fluorescein—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000529	0.00306	CcSEcCtD
Fluorescein—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000529	0.00305	CcSEcCtD
Fluorescein—Shock—Betamethasone—psoriatic arthritis	0.000527	0.00304	CcSEcCtD
Fluorescein—Shock—Dexamethasone—psoriatic arthritis	0.000527	0.00304	CcSEcCtD
Fluorescein—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000526	0.00304	CcSEcCtD
Fluorescein—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000525	0.00303	CcSEcCtD
Fluorescein—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000525	0.00303	CcSEcCtD
Fluorescein—Tachycardia—Dexamethasone—psoriatic arthritis	0.000522	0.00302	CcSEcCtD
Fluorescein—Tachycardia—Betamethasone—psoriatic arthritis	0.000522	0.00302	CcSEcCtD
Fluorescein—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000517	0.00299	CcSEcCtD
Fluorescein—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000517	0.00299	CcSEcCtD
Fluorescein—Malaise—Prednisone—psoriatic arthritis	0.000515	0.00298	CcSEcCtD
Fluorescein—Syncope—Prednisone—psoriatic arthritis	0.000512	0.00296	CcSEcCtD
Fluorescein—Urticaria—Prednisolone—psoriatic arthritis	0.00051	0.00295	CcSEcCtD
Fluorescein—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000509	0.00294	CcSEcCtD
Fluorescein—Pain—Triamcinolone—psoriatic arthritis	0.000504	0.00292	CcSEcCtD
Fluorescein—Loss of consciousness—Prednisone—psoriatic arthritis	0.000502	0.0029	CcSEcCtD
Fluorescein—Hypotension—Betamethasone—psoriatic arthritis	0.0005	0.00289	CcSEcCtD
Fluorescein—Hypotension—Dexamethasone—psoriatic arthritis	0.0005	0.00289	CcSEcCtD
Fluorescein—Angiopathy—Methotrexate—psoriatic arthritis	0.000498	0.00288	CcSEcCtD
Fluorescein—Immune system disorder—Methotrexate—psoriatic arthritis	0.000495	0.00286	CcSEcCtD
Fluorescein—Convulsion—Prednisone—psoriatic arthritis	0.000495	0.00286	CcSEcCtD
Fluorescein—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000494	0.00286	CcSEcCtD
Fluorescein—Hypertension—Prednisone—psoriatic arthritis	0.000493	0.00285	CcSEcCtD
Fluorescein—Chills—Methotrexate—psoriatic arthritis	0.000492	0.00284	CcSEcCtD
Fluorescein—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000486	0.00281	CcSEcCtD
Fluorescein—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000485	0.0028	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000483	0.00279	CcSEcCtD
Fluorescein—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000481	0.00278	CcSEcCtD
Fluorescein—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000481	0.00278	CcSEcCtD
Fluorescein—Paraesthesia—Betamethasone—psoriatic arthritis	0.000481	0.00278	CcSEcCtD
Fluorescein—Discomfort—Prednisone—psoriatic arthritis	0.00048	0.00278	CcSEcCtD
Fluorescein—Erythema—Methotrexate—psoriatic arthritis	0.000477	0.00276	CcSEcCtD
Fluorescein—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000473	0.00273	CcSEcCtD
Fluorescein—Urticaria—Triamcinolone—psoriatic arthritis	0.000469	0.00271	CcSEcCtD
Fluorescein—Urticaria—Methylprednisolone—psoriatic arthritis	0.000468	0.0027	CcSEcCtD
Fluorescein—Dysgeusia—Methotrexate—psoriatic arthritis	0.000467	0.0027	CcSEcCtD
Fluorescein—Oedema—Prednisone—psoriatic arthritis	0.000466	0.00269	CcSEcCtD
Fluorescein—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000466	0.00269	CcSEcCtD
Fluorescein—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000465	0.00269	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000462	0.00267	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000462	0.00267	CcSEcCtD
Fluorescein—Shock—Prednisone—psoriatic arthritis	0.000459	0.00265	CcSEcCtD
Fluorescein—Pain—Betamethasone—psoriatic arthritis	0.000458	0.00265	CcSEcCtD
Fluorescein—Pain—Dexamethasone—psoriatic arthritis	0.000458	0.00265	CcSEcCtD
Fluorescein—Nervous system disorder—Prednisone—psoriatic arthritis	0.000457	0.00264	CcSEcCtD
Fluorescein—Tachycardia—Prednisone—psoriatic arthritis	0.000455	0.00263	CcSEcCtD
Fluorescein—Skin disorder—Prednisone—psoriatic arthritis	0.000453	0.00262	CcSEcCtD
Fluorescein—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000451	0.0026	CcSEcCtD
Fluorescein—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000443	0.00256	CcSEcCtD
Fluorescein—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000441	0.00255	CcSEcCtD
Fluorescein—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000441	0.00255	CcSEcCtD
Fluorescein—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000438	0.00253	CcSEcCtD
Fluorescein—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000438	0.00253	CcSEcCtD
Fluorescein—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000435	0.00251	CcSEcCtD
Fluorescein—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000434	0.00251	CcSEcCtD
Fluorescein—Malaise—Methotrexate—psoriatic arthritis	0.00043	0.00249	CcSEcCtD
Fluorescein—Urticaria—Dexamethasone—psoriatic arthritis	0.000425	0.00246	CcSEcCtD
Fluorescein—Urticaria—Betamethasone—psoriatic arthritis	0.000425	0.00246	CcSEcCtD
Fluorescein—Dizziness—Prednisolone—psoriatic arthritis	0.000424	0.00245	CcSEcCtD
Fluorescein—Asthenia—Triamcinolone—psoriatic arthritis	0.000423	0.00245	CcSEcCtD
Fluorescein—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000423	0.00245	CcSEcCtD
Fluorescein—Abdominal pain—Betamethasone—psoriatic arthritis	0.000423	0.00245	CcSEcCtD
Fluorescein—Asthenia—Methylprednisolone—psoriatic arthritis	0.000422	0.00244	CcSEcCtD
Fluorescein—Paraesthesia—Prednisone—psoriatic arthritis	0.000419	0.00242	CcSEcCtD
Fluorescein—Pruritus—Triamcinolone—psoriatic arthritis	0.000417	0.00241	CcSEcCtD
Fluorescein—Cough—Methotrexate—psoriatic arthritis	0.000417	0.00241	CcSEcCtD
Fluorescein—Pruritus—Methylprednisolone—psoriatic arthritis	0.000416	0.00241	CcSEcCtD
Fluorescein—Convulsion—Methotrexate—psoriatic arthritis	0.000414	0.00239	CcSEcCtD
Fluorescein—Chest pain—Methotrexate—psoriatic arthritis	0.000406	0.00235	CcSEcCtD
Fluorescein—Rash—Prednisolone—psoriatic arthritis	0.000404	0.00234	CcSEcCtD
Fluorescein—Dermatitis—Prednisolone—psoriatic arthritis	0.000404	0.00234	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000404	0.00233	CcSEcCtD
Fluorescein—Headache—Prednisolone—psoriatic arthritis	0.000402	0.00232	CcSEcCtD
Fluorescein—Discomfort—Methotrexate—psoriatic arthritis	0.000402	0.00232	CcSEcCtD
Fluorescein—Dizziness—Triamcinolone—psoriatic arthritis	0.00039	0.00225	CcSEcCtD
Fluorescein—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00039	0.00225	CcSEcCtD
Fluorescein—Dizziness—Methylprednisolone—psoriatic arthritis	0.000389	0.00225	CcSEcCtD
Fluorescein—Feeling abnormal—Prednisone—psoriatic arthritis	0.000384	0.00222	CcSEcCtD
Fluorescein—Asthenia—Dexamethasone—psoriatic arthritis	0.000384	0.00222	CcSEcCtD
Fluorescein—Asthenia—Betamethasone—psoriatic arthritis	0.000384	0.00222	CcSEcCtD
Fluorescein—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000382	0.00221	CcSEcCtD
Fluorescein—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000381	0.0022	CcSEcCtD
Fluorescein—Nausea—Prednisolone—psoriatic arthritis	0.000381	0.0022	CcSEcCtD
Fluorescein—Pruritus—Dexamethasone—psoriatic arthritis	0.000379	0.00219	CcSEcCtD
Fluorescein—Pruritus—Betamethasone—psoriatic arthritis	0.000379	0.00219	CcSEcCtD
Fluorescein—Skin disorder—Methotrexate—psoriatic arthritis	0.000378	0.00219	CcSEcCtD
Fluorescein—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000377	0.00218	CcSEcCtD
Fluorescein—Vomiting—Triamcinolone—psoriatic arthritis	0.000375	0.00217	CcSEcCtD
Fluorescein—Vomiting—Methylprednisolone—psoriatic arthritis	0.000374	0.00216	CcSEcCtD
Fluorescein—Rash—Triamcinolone—psoriatic arthritis	0.000372	0.00215	CcSEcCtD
Fluorescein—Dermatitis—Triamcinolone—psoriatic arthritis	0.000372	0.00215	CcSEcCtD
Fluorescein—Rash—Methylprednisolone—psoriatic arthritis	0.000371	0.00214	CcSEcCtD
Fluorescein—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000371	0.00214	CcSEcCtD
Fluorescein—Urticaria—Prednisone—psoriatic arthritis	0.00037	0.00214	CcSEcCtD
Fluorescein—Headache—Triamcinolone—psoriatic arthritis	0.00037	0.00214	CcSEcCtD
Fluorescein—Headache—Methylprednisolone—psoriatic arthritis	0.000369	0.00213	CcSEcCtD
Fluorescein—Abdominal pain—Prednisone—psoriatic arthritis	0.000369	0.00213	CcSEcCtD
Fluorescein—Hypotension—Methotrexate—psoriatic arthritis	0.000364	0.0021	CcSEcCtD
Fluorescein—Dizziness—Dexamethasone—psoriatic arthritis	0.000354	0.00205	CcSEcCtD
Fluorescein—Dizziness—Betamethasone—psoriatic arthritis	0.000354	0.00205	CcSEcCtD
Fluorescein—Nausea—Triamcinolone—psoriatic arthritis	0.00035	0.00203	CcSEcCtD
Fluorescein—Paraesthesia—Methotrexate—psoriatic arthritis	0.00035	0.00202	CcSEcCtD
Fluorescein—Nausea—Methylprednisolone—psoriatic arthritis	0.00035	0.00202	CcSEcCtD
Fluorescein—Dyspnoea—Methotrexate—psoriatic arthritis	0.000347	0.00201	CcSEcCtD
Fluorescein—Hypersensitivity—Prednisone—psoriatic arthritis	0.000343	0.00198	CcSEcCtD
Fluorescein—Vomiting—Dexamethasone—psoriatic arthritis	0.00034	0.00197	CcSEcCtD
Fluorescein—Vomiting—Betamethasone—psoriatic arthritis	0.00034	0.00197	CcSEcCtD
Fluorescein—Rash—Dexamethasone—psoriatic arthritis	0.000338	0.00195	CcSEcCtD
Fluorescein—Rash—Betamethasone—psoriatic arthritis	0.000338	0.00195	CcSEcCtD
Fluorescein—Dermatitis—Dexamethasone—psoriatic arthritis	0.000337	0.00195	CcSEcCtD
Fluorescein—Dermatitis—Betamethasone—psoriatic arthritis	0.000337	0.00195	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000336	0.00194	CcSEcCtD
Fluorescein—Headache—Betamethasone—psoriatic arthritis	0.000335	0.00194	CcSEcCtD
Fluorescein—Headache—Dexamethasone—psoriatic arthritis	0.000335	0.00194	CcSEcCtD
Fluorescein—Asthenia—Prednisone—psoriatic arthritis	0.000334	0.00193	CcSEcCtD
Fluorescein—Pain—Methotrexate—psoriatic arthritis	0.000333	0.00193	CcSEcCtD
Fluorescein—Pruritus—Prednisone—psoriatic arthritis	0.00033	0.00191	CcSEcCtD
Fluorescein—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000321	0.00186	CcSEcCtD
Fluorescein—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000319	0.00184	CcSEcCtD
Fluorescein—Nausea—Dexamethasone—psoriatic arthritis	0.000318	0.00184	CcSEcCtD
Fluorescein—Nausea—Betamethasone—psoriatic arthritis	0.000318	0.00184	CcSEcCtD
Fluorescein—Urticaria—Methotrexate—psoriatic arthritis	0.000309	0.00179	CcSEcCtD
Fluorescein—Dizziness—Prednisone—psoriatic arthritis	0.000308	0.00178	CcSEcCtD
Fluorescein—Abdominal pain—Methotrexate—psoriatic arthritis	0.000308	0.00178	CcSEcCtD
Fluorescein—Vomiting—Prednisone—psoriatic arthritis	0.000296	0.00171	CcSEcCtD
Fluorescein—Rash—Prednisone—psoriatic arthritis	0.000294	0.0017	CcSEcCtD
Fluorescein—Dermatitis—Prednisone—psoriatic arthritis	0.000294	0.0017	CcSEcCtD
Fluorescein—Headache—Prednisone—psoriatic arthritis	0.000292	0.00169	CcSEcCtD
Fluorescein—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000287	0.00166	CcSEcCtD
Fluorescein—Asthenia—Methotrexate—psoriatic arthritis	0.00028	0.00162	CcSEcCtD
Fluorescein—Nausea—Prednisone—psoriatic arthritis	0.000277	0.0016	CcSEcCtD
Fluorescein—Pruritus—Methotrexate—psoriatic arthritis	0.000276	0.00159	CcSEcCtD
Fluorescein—Dizziness—Methotrexate—psoriatic arthritis	0.000258	0.00149	CcSEcCtD
Fluorescein—Vomiting—Methotrexate—psoriatic arthritis	0.000248	0.00143	CcSEcCtD
Fluorescein—Rash—Methotrexate—psoriatic arthritis	0.000246	0.00142	CcSEcCtD
Fluorescein—Dermatitis—Methotrexate—psoriatic arthritis	0.000245	0.00142	CcSEcCtD
Fluorescein—Headache—Methotrexate—psoriatic arthritis	0.000244	0.00141	CcSEcCtD
Fluorescein—Nausea—Methotrexate—psoriatic arthritis	0.000231	0.00134	CcSEcCtD
